Richard Aldrich, Director at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 20,000 shares at $19.76 ($395K) on 2015-12-16, disclosed to the SEC on 2015-12-17.
Scheduled sale ($395k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CNCE | SELL | 2018-02-01 | $356K | — | Filing → |
| CNCE | SELL | 2018-01-29 | $434K | — | Filing → |
| CNCE | SELL | 2018-01-24 | $689K | — | Filing → |